Balance Sheet for Vertex Pharmaceuticals Incorporated (VRTX)

$ 267.73   -0.45 (-0.17%) Volume: 1.1m 4:00 PM EDT 28-Sep-2020
After Hours:  $ 270.50   2.77 (+1.03%) Volume: 57.86k 6:29 PM EDT 28-Sep-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 3,109 2,650 1,665 1,184 715
Restrictable Cash - 26 1 48 79
Marketable Securities 699 518 423 251 328
Accounts Receivable 634 410 281 200 174
Loans Receivable - - - - -
Other Receivables - 67 105 35 -
Receivables 634 410 386 235 189
Inventories, Raw Materials 26 10 21 6 9
Inventories, Work in Progress 107 88 74 57 41
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 34 27 17 15 8
Inventories, Other 168 124 112 78 57
Inventories, Adjustments & Allowances - - - - -
Inventories 168 124 112 78 57
Prepaid Expenses 214 141 62 36 22
Current Deferred Income Taxes - - - - -
Other Current Assets - - - 17 13
Total Current Assets 4,823 3,843 2,649 1,832 1,407
Land and Improvements - - - - -
Buildings and Improvement 889 761 752 657 638
Machinery, Furniture and Equipment 548 503 470 429 395
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 1,438 1,263 1,222 1,086 1,034
Gross Fixed Assets 1,438 1,263 1,222 1,086 1,034
Accumulated Depreciation (693) (451) (432) (388) (336)
Net Fixed Assets 745 812 789 698 698
Intangibles 400 87 29 284 284
Cost in Excess 1,002 50 50 50 50
Non-Current Deferred Income Taxes 1,191 1,500 1 - -
Other Non-Current Assets 158 41 27 12 29
Total Non-Current Assets 3,496 2,403 897 1,065 1,091
Total Assets 8,318 6,246 3,546 2,897 2,499
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 186 212 147 107 135
Short Term Debt - 10 23 319 87
Notes Payable - - - - -
Accrued Expenses 946 815 603 268 223
Accrued Liabilities 946 815 603 268 223
Deferred Revenues - - 238 79 16
Current Deferred Income Taxes 167 (1,512) (121) 17 3
Other Current Liabilities 203 84 (203) 18 45
Total Current Liabilities 1,335 1,120 807 793 506
Long Term Debt N/A N/A N/A 521 739
Deferred Income Tax 253 - 6 134 110
Other Non-Current Liabilities 360 109 106 (186) 49
Minority Interest - - 14 182 154
Capital Lease Obligations 539 582 584 521 516
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 898 690 710 948 1,052
Total Liabilities 2,233 1,811 1,517 1,740 1,559
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 6,085 4,435 2,029 1,157 940
Common Par 3 3 3 2 2
Additional Paid in Capital 7,938 7,421 7,157 6,507 6,198
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,853) (2,989) (5,120) (5,374) (5,262)
Treasury Stock - - - - -
Other Equity Adjustments (2) 1 (12) 21 2
Total Capitalization 6,085 4,435 2,029 1,454 1,164
Total Equity 6,085 4,435 2,029 1,157 940
Total Liabilities & Shareholder's Equity 8,318 6,246 3,546 2,897 2,499
Cash Flow 1,177 2,087 92 (84) (588)
Working Capital 3,488 2,723 1,842 1,039 901
Free Cash Flow 1,494 1,175 586 180 (411)
Invested Capital 6,085 4,435 2,029 1,157 1,164
Shares Outstanding - Common Class Only 259 255 253 248 246
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 259 255 253 248 246
Total Common Shares Outstanding 259 255 253 248 246
Treasury Shares - 0 - - -
Basic Weighted Shares Outstanding 257 254 249 245 241
Diluted Weighted Shares Outstanding 261 259 253 245 241